FOLLOW US

America October 19, 2023 4 mins read

Sandoz Triumphs in Incontinence IP Battle Against Astellas

America ı By Rochdi Rais

0 Comments

Sandoz Triumphs in Incontinence IP Battle Against Astellas

Astellas has successfully defended one of its U.K. patents against two generic drug manufacturers in a high-stakes courtroom battle over a treatment for overactive bladder syndrome. Despite this, Astellas could not convince the judge that its competitor's product would infringe on its intellectual property.

In a comprehensive 102-page ruling, Judge Rachel Mellor, at the High Court, dismissed the arguments put forward by the defendants, Sandoz AG and Teva Pharmaceuticals, who contended that the patent for mirabegron, a specific compound, was invalid due to being obvious and failing to offer enough information for replication.

Teva had previously admitted that an earlier version of its generic product infringed the patent but did not introduce arguments concerning a new version in time for the trial. However, Astellas' infringement claims against Sandoz, a Swiss company, fell short of convincing the judge.

Judge Mellor found a lack of evidence regarding whether Sandoz's medication reduced the impact of food on the drug's absorption rate, a crucial element of Astellas' patent, which had been a subject of intense debate.

"Plausibility is a different standard to that required to prove infringement, and I have held that, to prove infringement, at least some reduction in food effect must be demonstrated … Astellas did not attempt to establish this, either directly or by inference via expert evidence," Judge Mellor explained.

It's known that food can influence the absorption of mirabegron, potentially diminishing its effectiveness. The judgment stated that Astellas aimed to create a product that allowed unrestricted food intake, a commercially sound strategy, as it's undesirable for a drug to require specific food consumption instructions.

Astellas resolved this issue by slowing down the drug's absorption rate, extending it beyond the conventional four hours to a maximum of seven hours, as detailed in the judgment.

The judge ultimately determined the validity of Astellas' patent based on her interpretation of a disputed phrase in the patent claim. The phrase "pharmaceutical composition for modified release" was seen as making a "promise" to reduce food's effects, even if it didn't explicitly state so, according to the judge.

Astellas had argued that the phrase didn't necessitate demonstrating that the medication reduced food's impact on absorption. However, the judge concluded that it did require at least "some" reduction. Hence, Astellas' invention was not considered obvious, making it unlikely that other scientists aiming to diminish food's impact on similar medications would have arrived at the same product.

Judge Mellor's rationale was that, even if undergraduate students could have theoretically worked on such a project part-time for a few weeks, there were only three identifiable routes to success, all of which would likely have led to abandonment by students or research teams.

The first route was flawed as it relied purely on hindsight. The second demanded "significant imagination" and the unlikely rejection of a vital piece of information. The third route would have forced any researcher to deviate entirely from conventional practice, which was deemed improbable.

However, Judge Mellor conceded that the patent would be invalidated if her interpretation of the phrase was incorrect.

The tribunal explored evidence provided by an expert, indicating that researchers would have likely developed around 20 similar formulations based on different drugs available in the market, reducing the effects of food. Some of these would fall within a broader interpretation of the patent claim.

This victory marks Astellas' successful defense in a series of allegations previously brought by the two generic drug manufacturers. An appeals court had previously upheld its patent for the same medication in July, acknowledging its "technical contribution" to the field.

As of now, neither Astellas, Teva, nor Sandoz have commented on the verdict.

The patent in question is European Patent EP (UK) 2,345,410.

Astellas is represented by Thomas Mitcheson KC of Three New Square and Anna Edwards-Stewart of 11 South Square, instructed by Hogan Lovells.

Teva is represented by Charlotte May KC of 8 New Square and Katherine Moggridge of Three New Square, instructed by Pinsent Masons LLP.

Sandoz is represented by Charlotte May KC of 8 New Square and Joe Delaney of Three New Square, instructed by Pinsent Masons LLP.

The case is Astellas Pharma Industries Ltd. v. Teva Pharmaceutical Industries Ltd., Teva U.K. Ltd., Sandoz A.G., and Sandoz Ltd., case number HP-2021-000014, in the Chancery Division of the High Court of Justice of England and Wales.

Previous Article

FCC Initiates Revival of Net Neutrality Rules: A Pivotal Showdown Begins

Read More
2774 Posts

Rochdi Rais

Rochdi Rais is the Head of Growth and financial and legal writer at USA Herald. He has been writing and editing financial, legal and U.S. news for years with over +4000 articles published during his career.

Discussion

No comments yet. Be the first to join the discussion!

Don’t Miss It
America November 18, 2026 13 U.S. Babies Born With Measles as Outbreaks Spread By – Michallie K Harrison
America November 17, 2026 NSA Classified Internal Network Goes Offline By – Jackie Allen
America November 17, 2026
Global Cyberattack Fears Grow as NSA,…

WASHINGTON – Over the past several weeks, hackers have interfered…

By – Samuel Lopez
America November 17, 2026
Aon completes $17B acquisition of USI

The Aon $17B acquisition of USI has crossed the finish…

By – Rachel Moore
America November 17, 2026
Cyber Attack Today: Hackers Hide Malicious…

The cyber attack today has turned some of the internet’s…

By – Rachel Moore
America November 17, 2026
Apple services, including iCloud and the…

The Apple outage is the latest in a string of…

By – Rachel Moore
America November 17, 2026
classified US national security communications network…

The NSA network down story landed with a jolt. The…

By – Rachel Moore
America November 17, 2026
Microsoft Apologizes After Worldwide Outlook Outage,…

Microsoft has apologized to customers and business partners following a…

By – Jackie Allen
America November 17, 2026
California Sues OpenAI After Rogue AI…

By Samuel A. Lopez – USA Herald SAN FRANCISCO –…

By – Samuel Lopez
America November 17, 2026
Widespread Technology Disruption in Major Banks,…

NEW YORK — A wave of technology disruption has affected…

By – Jackie Allen
America November 17, 2026
Content Creator Chrisean Rock Faces Looming…

By Samuel Lopez – USA Herald INGLEWOOD, Calif. – What…

By – Samuel Lopez
America November 17, 2026
“Not the Wild West”: California Sues…

California sues OpenAI, alleging about 700 AI agents hacked Hugging…

By – Derek Johnson
America November 17, 2026
Voyager 1 Is About to Become…

Voyager 1 reaches one light-day from Earth, about 16.1 billion…

By – Derek Johnson
America November 17, 2026
Optimizely Hack Turns Trusted Websites Into…

An Optimizely hack exposed visitors to malicious code through website…

By – Michallie K Harrison
America November 16, 2026
Iran Dirty Bomb Report Sparks U.S.…

WASHINGTON — An Iran dirty bomb report describes U.S. contingency…

By – Michallie K Harrison
America November 16, 2026
FBI Investigates Explosive Device at Illinois…

PEORIA, Illinois — Federal authorities are investigating an explosive device…

By – Jackie Allen
America November 16, 2026
Sneaker Wave Nearly Sweeps Oregon Woman…

SECRET BEACH, Oregon — A peaceful day along Oregon’s rugged…

By – Jackie Allen
America November 16, 2026
Robert Pattinson Named New James Bond:…

LONDON — Robert Pattinson has been named the newest actor…

By – Jackie Allen
America November 16, 2026
Mystery Star System Transmits Radio Signals…

PERTH, Australia — Astronomers have discovered an unusual star system…

By – Jackie Allen
America November 16, 2026
U.S. Soldiers Googled Hospitals After Deadly…

WASHINGTON — U.S. soldiers used Google to find hospitals after…

By – Michallie K Harrison
America November 16, 2026
“Bring Jensen Back”: Elon Musk and…

SANTA CLARA, Calif. — Just days after Jensen Huang resigned…

By – Derek Johnson
America November 16, 2026
Texas Man Executed for Beheading Three…

HUNTSVILLE, Texas — A 46-year-old Texas man convicted of murdering…

By – Jackie Allen
America November 15, 2026
Roseville Home Shooting: Two Found Dead…

The Roseville home shooting began as a call that sounded…

By – Rachel Moore
America November 15, 2026
S.C. Man Sentenced to Life in…

MYRTLE BEACH, S.C. — A South Carolina man has been…

By – Jackie Allen
America November 15, 2026
UPS and Copa Airlines Planes Collide…

The moment the UPS and Copa Airlines planes collided at…

By – Tyler Brooks
America November 15, 2026
FAA Ground Stop: Duffy Refuses to…

The FAA ground stop left hundreds of thousands of travelers…

By – Tyler Brooks
America November 15, 2026
Hackers Hit America’s Drinking Water Systems…

ATLANTA – Hackers have crossed a dangerous line in America’s…

By – Samuel Lopez
America November 15, 2026
America Loses Its Measles-Free Status for…

WASHINGTON, D.C. — For the first time in a quarter…

By – Derek Johnson
America November 11, 2026
Brooklyn Building Collapse Kills 2 as…

A Brooklyn building collapse killed at least two people and…

By – Michallie K Harrison
America November 11, 2026
A Veterans Day Betrayal: House Advances…

OPINION | The Republican-led House marked Veterans Day by advancing…

By – Michallie K Harrison
America November 11, 2026
AI Godfather Warns of Chernobyl-Style Blackout…

By Samuel López | USA Herald | November 11, 2026…

By – Samuel Lopez
America November 10, 2026
Vitamin K Deficiency Bleeding: Why the…

A single injection administered in the first hours of life…

By – Tyler Brooks
America November 15, 2026
Tower Hill Investment in Gator Athletics:…

The Tower Hill investment in Gator Athletics just rewrote the…

By – Tyler Brooks
America November 14, 2026
Golden State Valkyries Star Gabby Williams…

 Golden State Valkyries forward Gabby Williams believes Indiana Fever star…

By – Jackie Allen
America November 8, 2026
Dana White Reportedly Declines Trump White…

By Samuel Lopez – USA Herald | November 8, 2026…

By – Samuel Lopez
America November 7, 2026
Mike Tyson And Ric Flair Score…

Inside the $50 Million Legal Battle A federal judge rejected…

By – Samuel Lopez
America November 5, 2026
Dallas Cowboys Face  Crisis After Crushing…

By Jackie Allen | USA Herald The Dallas Cowboys are…

By – Jackie Allen
America November 4, 2026
WNBA: DeWanna Bonner Makes Emotional Admission…

ATLANTA — The WNBA Finals ended in heartbreak for the…

By – Jackie Allen

No posts found.

No posts found.

Signup for the USA Herald
exclusive Newsletter